A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.

Front Neurol · 2018 · PMC6304418 · PMID 30619047

Europe PMC DOI

hedged sentence

0.0300

closest p · 0.6× alpha

0.0300

boldest claim

The sentences

a significant trendp = 0.030actually significant

We found a significant trend of prolonged survival when comparing the three groups (log-rank test for trend; p = 0.030) as can be seen in Figure 4A , which depicts Kaplan-Meier curves of the three different treatment groups.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.